AL
ALZCF.US AlzChem Group AG
- Market cap
- USD 1.53B
- P/E
- 20.3x
- P/B
- 4.92x
- ROE
- 22.9%
- Dividend yield
- 1.62%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ALZCF.US undervalued?
Graham numberALZCF.US trades 110.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AlzChem Group AG fundamental analysis
No fundamental analysis for AlzChem Group AG yet.
AlzChem Group AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This se…
Full company profileAlzChem Group AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
AlzChem Group AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 327M | 354M | 375M | 376M | 379M | 422M | 542M | 541M | 554M | 562M | 592M |
| Gross Profit | 85.8M | 224M | 232M | 237M | 251M | 268M | 283M | 299M | 361M | 178M | 254M |
| Operating Income | -28.4K | 32.2M | 40.4M | 30.9M | 31.0M | 38.2M | 61.4M | 143M | 78.1M | 82.8M | 92.7M |
| EBITDA | 43.2M | 46.3M | 49.8M | 50.3M | 54.1M | 62.7M | 69.9M | 81.8M | 107M | 109M | 125M |
| Net Income | -28.8K | 20.4M | 22.6M | 18.0M | 19.7M | 27.6M | 30.1M | 34.6M | 54.1M | 63.4M | 64.4M |
| EPS | -0.13 | 2.00 | 2.23 | 1.77 | 1.94 | 2.72 | 2.96 | 3.40 | 5.31 | 6.28 | 6.39 |
| Balance Sheet | |||||||||||
| Total Assets | 64.4K | 280M | 314M | 343M | 354M | 378M | 423M | 425M | 484M | 617M | 674M |
| Total Liabilities | 64.4K | 222M | 245M | 281M | 286M | 288M | 277M | 261M | 276M | 359M | 393M |
| Shareholders' Equity | -51.0K | 55.7M | 67.0M | 59.8M | 66.9M | 87.6M | 144M | 162M | 206M | 256M | 281M |
| Cash & Short-term Investments | 2.01K | 13.3M | 13.0M | 9.25M | 17.5M | 8.73M | 9.62M | 13.9M | 63.2M | 78.2M | 63.8M |
| Total Debt | 30.6M | 41.5M | 57.9M | 72.1M | 69.1M | 55.6M | 100M | 62.5M | 52.8M | 44.2M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -36.1K | 30.7M | 34.7M | 43.6M | 48.7M | 43.0M | -4.24M | 72.7M | 105M | 137M | 130M |
| Capital Expenditure | 18.5M | 24.9M | 40.1M | 41.4M | 28.8M | 28.5M | 29.1M | 20.6M | 43.1M | 97.8M | 0.00 |
| Free Cash Flow | -18.6M | 5.79M | -5.47M | 2.25M | 19.9M | 14.5M | -33.3M | 52.1M | 105M | 39.2M | 130M |
| Ratios | |||||||||||
| ROE | - | 36.6% | 33.8% | 30.1% | 29.4% | 31.5% | 20.9% | 21.4% | 26.3% | 24.8% | 22.9% |
| ROA | -44.7% | 7.3% | 7.2% | 5.2% | 5.6% | 7.3% | 7.1% | 8.2% | 11.2% | 10.3% | 9.6% |
| Net Profit Margin | 0.0% | 5.8% | 6.0% | 4.8% | 5.2% | 6.5% | 5.5% | 6.4% | 9.8% | 11.3% | 10.9% |
| Debt to Equity | - | 0.75x | 0.87x | 1.21x | 1.03x | 0.63x | 0.70x | 0.39x | 0.26x | 0.17x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
AlzChem Group AG dividends
- Dividend yield
- 1.62%
- Forward dividend
- 2.46 USD
- Payout ratio
- 28.7%
- Ex-dividend date
- May 6, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 18.2M | 1.80 | 28.7% |
| 2024 | EUR 12.2M | 1.20 | 22.6% |
| 2023 | EUR 10.7M | 1.05 | 30.9% |
| 2022 | EUR 10.1M | 1.00 | 33.7% |
| 2021 | USD 7.82M | 0.77 | 28.3% |
| 2020 | USD 7.63M | 0.75 | 38.8% |
| 2019 | USD 9.16M | 0.90 | 51.0% |
| 2018 | USD 11.2M | 1.10 | 49.4% |
| 2017 | USD 17.8M | 1.75 | 87.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns AlzChem Group AG
- Insiders 31.94%
- Institutions 45.54%
- Public & others 22.53%
- Shares outstanding 10.1M
- Free float 6.22M
AlzChem Group AG company profile
- Company name
- AlzChem Group AG
- Ticker
- ALZCF.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,565
- Fiscal year end
- December
- Address
- Dr.-Albert-Frank-Strasse 32, Trostberg, Germany, 83308
- Phone
- 49 8621 86 0
- Website
- alzchem.com
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS " BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.
AlzChem Group AG management
4- Mr. Andreas NiedermaierCEO & Chairman of Executive Board · born 1969
- Mr. Andreas LoslerCFO & Member of Management Board · born 1975
- Ms. Martina SpitzerChief Sales Officer & Member of Management Board · born 1983
- Dr. Jurgen SansCOO & Member of Management Board · born 1968